These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 34454947)
1. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells. Jung YY; Baek SH; Narula AS; Namjoshi OA; Blough BE; Ahn KS Life Sci; 2021 Nov; 284():119893. PubMed ID: 34454947 [TBL] [Abstract][Full Text] [Related]
2. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation. Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359 [TBL] [Abstract][Full Text] [Related]
3. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells. Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309 [TBL] [Abstract][Full Text] [Related]
4. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308 [TBL] [Abstract][Full Text] [Related]
5. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253 [TBL] [Abstract][Full Text] [Related]
6. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway. Lee JH; Chinnathambi A; Alharbi SA; Shair OHM; Sethi G; Ahn KS Pharmacol Res; 2019 Dec; 150():104504. PubMed ID: 31678208 [TBL] [Abstract][Full Text] [Related]
7. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
8. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition. Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617 [TBL] [Abstract][Full Text] [Related]
9. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195 [TBL] [Abstract][Full Text] [Related]
10. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
11. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition. Shao L; Li H; Chen J; Song H; Zhang Y; Wu F; Wang W; Zhang W; Wang F; Li H; Tang D Biochem Biophys Res Commun; 2017 Apr; 485(3):598-605. PubMed ID: 27986567 [TBL] [Abstract][Full Text] [Related]
12. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
14. Isoviolanthin Extracted from Xing S; Yu W; Zhang X; Luo Y; Lei Z; Huang D; Lin J; Huang Y; Huang S; Nong F; Zhou C; Wei G Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882900 [No Abstract] [Full Text] [Related]
15. Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-κB signaling in colorectal cancer cells. Liang L; Huang J Oncol Rep; 2016 Sep; 36(3):1333-8. PubMed ID: 27430890 [TBL] [Abstract][Full Text] [Related]
16. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
17. Structure Identification of ViceninII Extracted from Luo Y; Ren Z; Du B; Xing S; Huang S; Li Y; Lei Z; Li D; Chen H; Huang Y; Wei G Molecules; 2019 Jan; 24(1):. PubMed ID: 30609689 [TBL] [Abstract][Full Text] [Related]
18. The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma. Yu CC; Huang SY; Chang SF; Liao KF; Chiu SC Molecules; 2020 May; 25(10):. PubMed ID: 32466169 [TBL] [Abstract][Full Text] [Related]
19. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells. Cheng KY; Hao M Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743 [TBL] [Abstract][Full Text] [Related]
20. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling. Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]